A Second Opinion: The Role of Cardiac Revascularization in Kidney Transplant Candidates

Background: Pre-kidney transplant (KTX) cardiac risk stratification currently relies on protocols developed for non-transplant end-stage renal disease (ESRD) populations and a positive stress test (+ST) is often not followed by cardiac catheterization (CC). We investigated whether patients who receive CC after +ST and +/- revascularization improve survival and transplant outcomes. Methods: Using the TriNetX Research Network, we identified adults who underwent KTX (2004–2024) and had a +ST within five years prior. +ST patients were grouped by whether they received CC (n=11,171) or not (n=47,833) and whether those with CC had following revascularization (n = 2,891) or not (n=8,280). Propensity score matching by demographic and cardiovascular factors yielded 2,853 patients per group. Primary outcomes were one-year mortality and five-year transplant complications.Using the TriNetX Research Network, we identified adults who underwent KTX (2004–2024) and had a +ST within five years prior. +ST patients were grouped by whether they received CC (n=11,171) or not (n=47,833) and whether those with CC had following revascularization (n = 2,891) or not (n=8,280). Propensity score matching by demographic and cardiovascular factors yielded 2,853 patients per group. Primary outcomes were one-year mortality and five-year transplant complications. Results: Among propensity matched KTX recipients, those who underwent CC with subsequent revascularization experienced significantly lower one-year mortality (RR, 1.446; 95% CI, 1.034-2.062) and five-year kidney transplant complications (RR: 0.847; 95% CI, (0.782-0.916) compared to those who did not. This suggests a potential benefit of CC following +ST and revascularization in optimizing patient survival and early post-transplant outcomes. Conclusion: In our cohort, patients who underwent +ST evaluation with subsequent revascularization exhibited the highest survival rates.These data suggest that during pre-KTX evaluation, CC should routinely follow a +ST, and revascularization should be pursued when indicated. This approach is associated with the best survival in this patient population. Funding: Other NIH Support - Study supported in part by a Clinical and Translational Science Award (UL1 TR001439)

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025e46svf0e
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Second Opinion: The Role of Cardiac Revascularization in Kidney Transplant Candidates

George Golovko, Cristiana Rastellini, Joshua Wang, Sudhanvan Iyer et al.
Journal of the American Society of Nephrology
Renal Transplantation Outcomes and Treatments
article

A Second Opinion: The Role of Cardiac Revascularization in Kidney Transplant Candidates

George Golovko, Cristiana Rastellini, Joshua Wang, Sudhanvan Iyer, Ali Shirafkan, Phi‐Yen Nguyen, Luca Cicalese
article en

Abstract

Background: Pre-kidney transplant (KTX) cardiac risk stratification currently relies on protocols developed for non-transplant end-stage renal disease (ESRD) populations and a positive stress test (+ST) is often not followed by cardiac catheterization (CC). We investigated whether patients who receive CC after +ST and +/- revascularization improve survival and transplant outcomes. Methods: Using the TriNetX Research Network, we identified adults who underwent KTX (2004–2024) and had a +ST within five years prior. +ST patients were grouped by whether they received CC (n=11,171) or not (n=47,833) and whether those with CC had following revascularization (n = 2,891) or not (n=8,280). Propensity score matching by demographic and cardiovascular factors yielded 2,853 patients per group. Primary outcomes were one-year mortality and five-year transplant complications.Using the TriNetX Research Network, we identified adults who underwent KTX (2004–2024) and had a +ST within five years prior. +ST patients were grouped by whether they received CC (n=11,171) or not (n=47,833) and whether those with CC had following revascularization (n = 2,891) or not (n=8,280). Propensity score matching by demographic and cardiovascular factors yielded 2,853 patients per group. Primary outcomes were one-year mortality and five-year transplant complications. Results: Among propensity matched KTX recipients, those who underwent CC with subsequent revascularization experienced significantly lower one-year mortality (RR, 1.446; 95% CI, 1.034-2.062) and five-year kidney transplant complications (RR: 0.847; 95% CI, (0.782-0.916) compared to those who did not. This suggests a potential benefit of CC following +ST and revascularization in optimizing patient survival and early post-transplant outcomes. Conclusion: In our cohort, patients who underwent +ST evaluation with subsequent revascularization exhibited the highest survival rates.These data suggest that during pre-KTX evaluation, CC should routinely follow a +ST, and revascularization should be pursued when indicated. This approach is associated with the best survival in this patient population. Funding: Other NIH Support - Study supported in part by a Clinical and Translational Science Award (UL1 TR001439)

Journal of the American Society of NephrologyVol. 36(10S)
John Sealy Hospital (US)
Openalex Percentile: Top 48%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.